• Professor and Chair of the Department
  of Medical and Molecular Genetics
• Professor of Microbiology & Immunology
• Director, Indiana University Vector Facility
• Coordinating Director, National Gene Vector Laboratories

• Campus Address; IB 135
• Telephone: (317) 274-2240
• E-mail: kcornett@iupui.edu

Hal Broxmeyer named distinguished professor at IUSM (click here for more details)

Janice Blum discusses Immunology & Infectious Diseases (click here for more details)

Training:
• B.S. 1978 - State University of New York; Albany NY
• M.D. 1982 - Albany Medical College; Albany, NY

Description and summary of research focus of the laboratory:
Dr. Cornetta's laboratory is interested in the use of gene transfer in the treatment of human malignancies. The laboratory is particulary interested in the development and use of retroviral and lentiviral (HIV-1) based vectors. Three areas of active research are being explored. The first aims to efficiently transduce human bone marrow progenitor cells from cancer patients with retroviral vectors expressing drug resistance genes. Their second area of research aims to develop tumor vaccines for breast cancer and leukemia that utilize vector technology. Lastly, the Indiana University Vector Production Facility, a designated NIH National Gene Vector Laboratory, is charged with generating clinical grade vector for human gene therapy trials. Research in this area aims to optimize and understand gene transduction gene expression, with emphasis on potential clinical applications.

Publications
Abonour, R., Williams, D.A., Einhorn, L., Hall, K.M., Chen, J., Coffman, J., Traycoff, C.M., Bank, A., Kato, I., Ward, M., Williams, S.D., Hromas, R., Robertson, M.J., Smith, F.O., Woo, D., Mills, B., Srour, E.F., Cornetta, K.   Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem.   Nature Medicine 6:652-658, 2000.

Cornetta, K. and Smith, F.O.   Regulatory issues for clinical gene therapy trials.   Human Gene Therapy 13:1143-1149, 2002.

Duffy, L., Koop, S., Fyffe, J., and Cornetta, K.   Extended S+/L- assay for detecting replication competent retroviruses pseudotyped with the RD114 viral envelope.   Preclinica May/June:53-59, 2003.

Sastry, L., Xu, Y., Johnson, T., Desai, K., Rissing, D., Marsh, J., and Cornetta, K.   Certification assays for HIV1-based vectors: Frequent passage of gag sequences without evidence of replication competent viruses.   Molecular Therapy 8:830-839, 2003.

Kahl, C.A., Marsh, J., Fyffe, J., Sanders, D.A., and Cornetta, K.   Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from ross river virus and semliki forest virus.   Journal of Virology 78:1421-1430, 2004.

Search Pub Med

Return to Homepage